CEERAM
Provider of in vitro diagnostic solutions focused on infectious diseases, antimicrobial resistance, sepsis management, food safety and pharmaceutical quality control. The organization offers molecular and culture-based diagnostic workflows, mass spectrometry identification, immunoassays, laboratory informatics, and industry-focused testing systems for clinical and industrial laboratories.
Industries
Nr. of Employees
small (1-50)
Products
Rapid multiplex PCR respiratory panel (CLIA-waived)
A rapid molecular respiratory panel that detects multiple common respiratory viruses and bacteria with an approximately 15-minute turnaround for point-of-care use.
MALDI-TOF mass spectrometry microbial identification system
Mass spectrometry-based system for automated identification of microorganisms in clinical and industrial laboratories.
Automated blood culture detection system
Fully automated blood culture incubation and detection platform with continuous monitoring and real-time notifications.
Procalcitonin biomarker immunoassay for antibiotic stewardship
Immunoassay providing rapid procalcitonin results to inform antibiotic therapy decisions.
Real-time PCR and automated pathogen detection for industry QC
PCR-based pathogen detection systems and automated enumeration instruments for food safety and pharmaceutical quality control.
Mycoplasma detection kits for manufacturing testing
Nucleic acid–based assays for in-house detection of mycoplasma in raw materials, in-process samples, and final product release.
Rapid multiplex PCR respiratory panel (CLIA-waived)
A rapid molecular respiratory panel that detects multiple common respiratory viruses and bacteria with an approximately 15-minute turnaround for point-of-care use.
MALDI-TOF mass spectrometry microbial identification system
Mass spectrometry-based system for automated identification of microorganisms in clinical and industrial laboratories.
Automated blood culture detection system
Fully automated blood culture incubation and detection platform with continuous monitoring and real-time notifications.
Procalcitonin biomarker immunoassay for antibiotic stewardship
Immunoassay providing rapid procalcitonin results to inform antibiotic therapy decisions.
Real-time PCR and automated pathogen detection for industry QC
PCR-based pathogen detection systems and automated enumeration instruments for food safety and pharmaceutical quality control.
Mycoplasma detection kits for manufacturing testing
Nucleic acid–based assays for in-house detection of mycoplasma in raw materials, in-process samples, and final product release.
Services
Software solutions to connect laboratory workflows, manage sample traceability, and aggregate data from instruments.
Online ordering and account management for diagnostic kits and consumables.
Software solutions to connect laboratory workflows, manage sample traceability, and aggregate data from instruments.
Online ordering and account management for diagnostic kits and consumables.
Expertise Areas
- Infectious disease diagnostics
- Antimicrobial resistance testing and surveillance
- Molecular diagnostics (PCR and real-time PCR)
- Microbiology automation and instrumentation
Key Technologies
- Multiplex PCR
- Rapid point-of-care molecular testing
- Real-time PCR
- MALDI-TOF mass spectrometry
News & Updates
Announcement of a research-use-only sequencing-based solution to rapidly characterize mutations associated with antimicrobial resistance in Mycobacterium tuberculosis complex.
Business review reporting consolidated sales and quarterly business performance.
Summary of a published study investigating a rapid 15-plex PCR respiratory panel showing reduced antibiotics and time savings in ED patients with suspected acute respiratory infection.
Publication of a Bioethics Charter describing commitments to transparency, accountability, and participant protection in clinical research and sample/data use.
Announcement of a research-use-only sequencing-based solution to rapidly characterize mutations associated with antimicrobial resistance in Mycobacterium tuberculosis complex.
Business review reporting consolidated sales and quarterly business performance.
Summary of a published study investigating a rapid 15-plex PCR respiratory panel showing reduced antibiotics and time savings in ED patients with suspected acute respiratory infection.
Publication of a Bioethics Charter describing commitments to transparency, accountability, and participant protection in clinical research and sample/data use.